Fig. 5From: Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expressionImmunoexpression of vimentin in the bladder cancer cohort. a, b: immunoexpression of vimentin in primary bladder cancer specimens, one NMIBC (a) and one MIBC (b); c and d: immunoexpression of vimentin in bladder cancer metastasesBack to article page